Fluid Restriction Keeps Children Dry (LESSER)

December 7, 2016 updated by: J.B.M. van Woensel, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Fluids in Mechanically Ventilated Children With Acute Infectious Lung Disease: How Dry Should They be?

Rationale: Fluid overload is a common complication in children who are admitted to the pediatric intensive care for mechanical ventilation. Acute lung infection is a frequent cause for admission to the PICU and forms an uniform group with a single organ failure. In these critically ill children, fluid overload is associated with adverse outcome. Restricting the volume of fluids already in an early stage of ICU admission may prevent fluid overload during mechanical ventilation and thus improve clinical outcome. However, at the same time fluid restriction may interfere with appropriate energy and macronutrient intake that is needed for recovery.

Objective: The main goal of this pilot study is to evaluate the feasibility of a restrictive fluid management protocol and investigate its effect on the occurrence of fluid overload in mechanically ventilated children with acute infectious lung disease.

Study design: Single-center prospective randomized feasibility and pilot study in preparation of a multi-center randomized controlled trial (RCT).

Study population: Mechanically ventilated children with (suspicion of) acute infectious lung disease admitted to the pediatric intensive care unit (PICU) of the Emma Children's Hospital, Academic Medical Center, Amsterdam.

Intervention: Patients receive either liberal (control group) or a restrictive (experimental group) fluid treatment, while ensuring appropriate caloric intake.

Main study parameters/endpoints: Primary outcomes are cumulative fluid balance and body weight during the first week of mechanical ventilation. Secondary outcomes (in preparation of the larger multi-center RCT) include: mortality, duration of mechanical ventilation and oxygenation indices. To determine the feasibility, in- and exclusion rate, adherence to treatment arms, need for fluid bolus, need for diuretics and hemodynamic indices as well as energy and protein intake are studied.

Both fluid management protocols reflect a variant of current clinical practice, hence will not provide extra burden or risk to patients included in the study. Patients will be randomized to either of the fluid protocol arms on admission to the PICU (at start of mechanical ventilation). Patients included in the restrictive fluid treatment arm might have direct benefit from the study if indeed fluid overload is less common in this group.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

34

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amsterdam, Netherlands
        • Recruiting
        • Academic Medical Center
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Sarah A Ingelse, MD
        • Sub-Investigator:
          • Reinout A Bem, MD PhD
        • Principal Investigator:
          • Job BM van Woensel, Professor (MD PhD)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 week to 10 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Signed informed consent by parents or legal caretakers
  • Admitted to the PICU of the Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands
  • Intubated and mechanically ventilated, with an anticipated duration of mechanical ventilation of at least 72 hours at enrolment (as judged by investigator or pediatrician on duty)
  • Patients with an acute infectious lung disease, including (suspected) viral, bacterial or fungal infection

Exclusion Criteria:

  • Patients in need of a particular fluid regimen (either restrictive or liberal) due to their medical history (e.g. cardiovascular disease and/or congenital (cyanotic) heart disease)
  • Use of previous and/or maintenance diuretic treatment
  • Ongoing (fluid) resuscitation on admission
  • Acute kidney injury with need for renal replacement therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Restrictive fluid treatment
Restrictive fluid regimen
In this treatment arm, patients will receive a maximal daily fluid intake of 70% of normal requirements (for a healthy child).
ACTIVE_COMPARATOR: Liberal fluid treatment
This is seen as current standard clinical treatment, wherein patients will receive a more liberal fluid regimen.
This is considered current standard clinical treatment, wherein patients will receive a fluid regimen of >85% of normal fluid recommendations (for a healthy child).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cumulative fluid balance
Time Frame: First week of mechanical ventilation
First week of mechanical ventilation
Body weight
Time Frame: First week of mechanical ventilation
First week of mechanical ventilation

Secondary Outcome Measures

Outcome Measure
Time Frame
Duration of mechanical ventilation
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Oxygenation indices
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Mortality
Time Frame: Up to 90 days after admission
Up to 90 days after admission

Other Outcome Measures

Outcome Measure
Time Frame
In- and exclusion rate
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Adherence to treatment arms
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Need for fluid bolus
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Need for diuretics
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Need for vasopressors or inotropic drugs
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Energy and protein intake
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Gastrointestinal complaints
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Hemodynamic indices
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week
Occurrence of electrolyte imbalances
Time Frame: Through study completion, an average of 1 week
Through study completion, an average of 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (ANTICIPATED)

September 1, 2018

Study Completion (ANTICIPATED)

November 1, 2018

Study Registration Dates

First Submitted

December 5, 2016

First Submitted That Met QC Criteria

December 7, 2016

First Posted (ESTIMATE)

December 12, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

December 12, 2016

Last Update Submitted That Met QC Criteria

December 7, 2016

Last Verified

December 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe